Intrinsic Value of S&P & Nasdaq Contact Us

Accolade, Inc. ACCD NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Information Services • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$7.03
+0.1%

Accolade, Inc. (ACCD) — Analyst outlook / Analyst consensus target is. Based on 20 analyst ratings, the consensus is bullish — 7 Buy, 13 Hold.

The consensus price target is $7.03, representing an upside of 0.1% from the current price $7.02.

ACCD Stock — 12-Month Price Forecast

$7.03
▲ +0.14% Upside
Average Price Target
Based on 20 Wall Street analysts offering 12-month price targets for Accolade, Inc., the price target is $7.03.
The average price target represents a +0.14% change from the last price of $7.02.

ACCD Analyst Ratings

Hold
20
Ratings
7 Buy
13 Hold
Based on 20 analysts giving stock ratings to Accolade, Inc. in the past 3 months
Rating breakdown
Buy
7 35%
Hold
13 65%
35%
Buy
7 analysts
65%
Hold
13 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message